FOR IMMEDIATE RELEASE

ELIZABETH ARDEN, INC. ANNOUNCES SECOND QUARTER
RESULTS FOR FISCAL 2007

~ Net Sales Increase of 19% ~
~ Fully Diluted EPS of $0.92 (Excluding Charges) ~
~ Raises Lower End of Full Year Fiscal 2007 EPS Guidance ~

          New York, New York (February 1, 2007) -- Elizabeth Arden, Inc. (NASDAQ: RDEN), a global prestige beauty products company, today announced financial results for the fiscal 2007 second quarter ended December 31, 2006.

SECOND QUARTER RESULTS

          Net sales increased 18.8% to $410.8 million for the three months ended December 31, 2006 from $345.9 million in the comparable period of the prior year. Sales growth was driven by a significant increase in fragrance brands sold to the Company's mass retail customers, sales of new brands, including the With Love...Hilary Duff fragrance and the fragrance brands resulting from the June 2006 Riviera Concepts acquisition. In addition, higher sales of the Company's Elizabeth Arden branded skin care and color products and growth in the Company's businesses in China and Taiwan contributed to the net sales increase. Excluding the favorable impact of foreign currency translation, net sales increased 17.3%.

          Net income for the three months ended December 31, 2006 was $26.2 million, or $0.92 per diluted share, excluding previously announced restructuring charges of $0.3 million after taxes related to the Company's restructuring in its European operations, compared to net income of $33.1 million, or $1.12 per diluted share, in the same period last year. On a reported basis, net income was $25.9 million, or $0.91 per diluted share. As previously announced, the Company's earnings for the second quarter of fiscal 2007 were impacted by transition and integration expenses associated with the Company's recent acquisitions.

          E. Scott Beattie, Chairman, President and Chief Executive Officer of Elizabeth Arden, Inc., commented, "We are pleased with our second quarter results and the general execution of our business. Our better than planned earnings reflect the strength of our broad-based business model, which spans multiple retail channels and geographies, as well as the strength of our brand portfolio. Overall, the recent acquisitions are performing ahead of our original expectations. We have completed the transition of the distribution activities out of the Sovereign Sales facility and are on schedule to integrate all remaining functions during the third fiscal quarter. Although With Love...Hilary Duff ranked among the top three Fall fragrance launches at U.S. department stores, our recently launched fragrances were short of our internal retail sales expectations, largely due to a softer than expected holiday season for fragrances at U.S. department stores. The rest of our business units, however, performed at or better than plan."

          Mr. Beattie continued, "Our U.S. mass retail business increased significantly, and we are expanding our market share. This growth was led by the acquisitions and the strength of the Britney Spears fragrance franchise, which experienced double-digit gains this quarter in sales to mass retailers as well as in our international markets."

          Mr. Beattie added, "In addition, net sales of our Elizabeth Arden branded skin care and color products rose 18% this quarter and 20% for the first half of the fiscal year. This is a result of our very strong product innovation and improved brand promotion and advertising globally. Our international business achieved another quarter of solid sales growth, with increases across most markets and particularly in Asia. Our focus on the Elizabeth Arden brand, including the introduction of products such as PREVAGE™ anti-aging treatment, is also resulting in improved retail sales and productivity at U.S. department stores. The repositioning of PREVAGE™ to the beauty counter, for example, has lifted the retail performance of our Elizabeth Arden skin care and color business."

SIX MONTHS RESULTS

          For the six-months ended December 31, 2006, net sales rose 16.1% to $665.6 million from $573.3 million for the six months ended December 31, 2005. Excluding the favorable impact of foreign currency translation, net sales increased 15.0%. Net income was $25.8 million, or $0.91 per diluted share, versus $34.0 million, or $1.15 million per diluted share, for the year-ago period. The results for the six months ended December 31, 2006 exclude restructuring charges of $1.2 million after taxes related to the Company's previously announced restructuring charges. On a reported basis, net income was $24.5 million, or $0.86 per diluted share.

OUTLOOK

          The Company confirms its fiscal 2007 annual net sales guidance. For the fiscal year, the Company currently anticipates net sales will increase by approximately 15% to 18%, assuming current foreign currency rates. The Company is raising the lower end of its fiscal 2007 earnings guidance range and currently estimates diluted earnings per share in the range of $1.15 to $1.20, versus its previous guidance range of $1.10 to $1.20.

          The Company currently expects net sales to range between $215 million to $230 million for each of the third and fourth fiscal quarters. Diluted earnings per share for the third fiscal quarter are currently estimated to be in the range of $0.01 to $0.06. The Company expects to incur in its third fiscal quarter the final transition expenses for the Sovereign Sales acquisition and increased investment to support the global roll-out of the With Love...Hilary Duff fragrance, PREVAGEä Eye skin treatment and the Intervene skin care line and the global launch of the new Elizabeth Arden fragrance, Elizabeth Arden Mediterranean.

          Mr. Beattie concluded, "As we look forward to the second half of the year, we are excited about the global introduction of the new Elizabeth Arden fragrance, Elizabeth Arden Mediterranean, to support the strong growth of the Elizabeth Arden skin care and color business globally. Prevage Eye continues to gain traction and is lifting total sales of the Prevage™ skin care line and the entire Elizabeth Arden skin care and color business. In addition, we anticipate sales from the recent acquisitions, a strong pipeline of new distributed brands in the U.S. mass retail market, the successful roll-out of recently launched brands and continued growth of our international business to contribute to the second half results."

CONFERENCE CALL INFORMATION

          The Company will host a conference call today at 10:00 a.m. Eastern Time. All interested parties can listen to a live web cast of the Company's conference call by logging on to the Company's web site at http://www.elizabetharden.com/Corporate/calendar_of_events.asp. An online archive of the broadcast will be available within one hour of the completion of the call and will be accessible on the Company's web site at www.elizabetharden.com until March 31 2007.

Elizabeth Arden is a global prestige beauty products company. The Company's portfolio of brands includes the Elizabeth Arden fragrance brands: Red Door, Elizabeth Arden 5^th Avenue, Elizabeth Arden green tea and Elizabeth Arden Provocative Woman; the Elizabeth Taylor fragrance brands: White Diamonds and Elizabeth Taylor's Passion; the fragrance brands of Britney Spears: curious Britney Spears and fantasy Britney Spears; the Hilary Duff fragrance With Love...Hilary Duff; the Danielle Steel fragrance Danielle by Danielle Steel; the classic fragrances: Design, Giorgio Beverly Hills, Halston and Halston Z-14, White Shoulders and Wings; the men's fragrances: Daytona 500, GANT, Geoffrey Beene's Grey Flannel, the HUMMER™ Fragrance for Men and PS Fine Cologne for Men; and the designer fragrance brands of Alfred Sung, Badgley Mischka and Bob Mackie; the Elizabeth Arden skin care lines, including Ceramide, Intervene and PREVAGE™ anti-aging treatment and the Elizabeth Arden color cosmetics line.

Company Contact:	Marcey Becker, Senior Vice President, Finance
	(203) 462-5809
Investor/Press Contact:	Allison Malkin/Michael Fox
	Integrated Corporate Relations
	(203) 682-8200

In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Elizabeth Arden, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance regarding net sales, earnings and cash flow from operations. In addition, any such statements are qualified in their entirety by reference to, and are accompanied by, the following key factors that have a direct bearing on our results of operations:

* our absence of contracts with customers or suppliers and our ability to maintain and develop relationships with customers and suppliers;

* international and domestic economic and business changes that could impact consumer confidence and or our customers' operations;

* the impact of competitive products and pricing;

* risks of international operations, including foreign currency fluctuations, economic and political consequences of terrorist attacks and political instability in certain regions of the world;

* unexpected factors affecting customer or consumer purchasing preferences and/or patterns;

* our ability to successfully launch new products and implement our growth strategy;

* the quality, safety and efficacy of our products;

* the success or changes in the timing or scope of advertising and merchandising programs;

* our ability to successfully and cost-effectively integrate acquired businesses or new brands;

* our substantial indebtedness, debt service obligations and restrictive covenants in our revolving credit facility and our indenture for our 7 3/4% senior subordinated notes;

* our customers' financial condition;

* our ability to access capital for acquisitions;

* changes in product mix to less profitable products;

* the retention and availability of key personnel;

* the assumptions underlying our critical accounting estimates;

* delays in shipments, inventory shortages and higher costs of production due to interruption of operations at key third party manufacturing or fulfillment facilities that manufacture or provide logistic services for the majority of our supply of certain products;

* the loss of or disruption in our distribution facilities;

* changes in the retail, fragrance and cosmetic industries, including the consolidation of retailers and the associated closing of retail doors as well as inventory control practices;

* our ability to protect our intellectual property rights;

* changes in the legal, regulatory and political environment that impact, or will impact, our business, including changes to customs or trade regulations or accounting standards; and

* other unanticipated risks and uncertainties.

We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

ELIZABETH ARDEN, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF OPERATIONS DATA

(Unaudited)

(In thousands, except percentages and per share data)

		Quarter Ended							Six Months Ended
			December 31,			December 31,				December 31,				December 31,
			2006			2005				2006				2005
Net Sales		$	410,771		$	345,893			$	665,579			$	573,271
Cost of Sales			252,817			200,133				408,399				338,445
Gross Profit			157,954			145,760				257,180				234,826
Gross Profit Percentage			38.5	%		42.1	%			38.6	%			41.0	%
Selling, General and Administrative Expenses			108,322			86,105				195,606				162,495
Depreciation and Amortization			6,350			5,376				12,698				10,649
Total Operating Expenses			114,672			91,481				208,304				173,144
Interest Expense, Net			8,529			6,662				15,889				12,776
Income Before Income Taxes			34,753			47,617				32,987				48,906
Provision for Income Taxes			8,897			14,523				8,445				14,916
Net Income		$	25,856		$	33,094		$		24,542		$		33,990
As reported:
	Basic Income Per Share	$	0.94		$	1.16		$		0.89		$		1.19
	Diluted Income Per Share	$	0.91		$	1.12		$		0.86		$		1.15
	Basic Shares		27,380			28,461				27,613				28,519
	Diluted Shares		28,410			29,484				28,482				29,615
	EBITDA (a)	$	49,632		$	59,655		$		61,574		$		72,331
Adjusted to exclude the effect of restructuring    charges, net of taxes (b):
	Net Income	$	26,205		$	33,094		$		25,783		$		33,990
	Basic Income Per Share	$	0.96		$	1.16		$		0.93		$		1.19
	Diluted Income Per Share	$	0.92		$	1.12		$		0.91		$		1.15
	Basic Shares		27,380			28,461				27,613				28,519
	Diluted Shares		28,410			29,484				28,482				29,615
EBITDA (a)		$	50,101		$	59,655		$		63,242		$		72,331

(a)    EBITDA is defined as net income plus the provision for income taxes, plus interest expense, plus depreciation and amortization. EBITDA should not be considered as an alternative to operating income or net income (as determined in accordance with generally accepted accounting principles (GAAP)) as a measure of our operating performance or to net cash provided by operating, investing and financing activities (as determined in accordance with GAAP) or as a measure of our ability to meet cash needs. We believe that EBITDA is a measure commonly reported and widely used by investors and other interested parties as a measure of a company's operating performance and debt servicing ability because it assists in comparing performance on a consistent basis without regard to capital structure, depreciation and amortization or non-operating factors (such as historical cost). Accordingly, as a result of our capital structure, we believe EBITDA is a relevant measure. This information has been disclosed here to permit a more complete comparative analysis of our operating performance relative to other companies and of our debt servicing ability. EBITDA may not, however, be comparable in all instances to other similar types of measures.

The following is a reconciliation of net income, as determined in accordance with GAAP, to EBITDA: (For a reconciliation of net income to EBITDA for prior periods, see the Company's filings with the Securities and Exchange Commission which can be found on the Company's website at www.elizabetharden.com).

		Three Months Ended		Six Months Ended
(In thousands)		December 31,	December 31,	December 31,	December 31,
		2006	2005	2006	2005
Net income		$25,856	$33,094	$24,542	$33,990
Plus:
	Provision for income taxes	8,897	14,523	8,445	14,916
	Interest expense, net	8,529	6,662	15,889	12,776
	Depreciation and amortization	6,350	5,376	12,698	10,649
EBITDA		49,632	59,655	61,574	72,331
Restructuring charges		469	--	1,668	--
EBITDA excluding restructuring charges		$50,101	$59,655	$63,242	$72,331

(b)   The following table reconciles the calculation of net income per share on a basic and diluted basis from the amounts reported in accordance with GAAP to such amounts before giving effect to the impact of restructuring charges. This disclosure is being provided because we believe it is meaningful to our investors and other interested parties to understand the Company's operating performance for comparability purposes and on a consistent basis without regard to the impact of restructuring charges. The presentation of the non-GAAP information titled "Net income per share as adjusted, before the effect of the restructuring charges, net of taxes" is not meant to be considered in isolation or as a substitute for net income or net income per share prepared in accordance with GAAP.

(In thousands, except per share data)			Three Months Ended				Six Months Ended
			December 31,		December 31,		December 31,		December 31,
			2006		2005		2006		2005
As reported:
Basic
	Net income as reported		$	25,856	$	33,094	$	24,542	$	33,990
	Weighted average shares outstanding as reported			27,380		28,461		27,613		28,519
		Net income per basic share as reported	$	0.94	$	1.16	$	0.89	$	1.19
Diluted
	Net income as reported		$	25,856	$	33,094	$	24,542	$	33,990
	Weighted average shares and potential dilutive   shares as reported			28,410		29,484		28,482		29,615
		Net income per diluted share as reported	$	0.91	$	1.12	$	0.86	$	1.15
Adjusted to exclude the effect of restructuring    charges, net of taxes
Basic
	Net income as reported		$	25,856	$	33,094	$	24,542	$	33,990
	Restructuring charges, net of tax			349		--		1,241		--
		Net income as adjusted, before the effect of    the restructuring charges, net of taxes	$	26,205	$	33,094	$	25,783	$	33,990
	Weighted average shares outstanding as reported			27,380		28,461		27,613		28,519
		Net income per share as adjusted, before the    effect of the restructuring charges, net of taxes	$	0.96	$	1.16	$	0.93	$	1.19
Diluted
	Net income as reported		$	25,856	$	33,094	$	24,542	$	33,990
	Restructuring charges, net of tax			349		--		1,241		--
		Net income as adjusted, before the effect of   the restructuring charges, net of taxes	$	26,205	$	33,094	$	25,783	$	33,990
	Weighted average shares outstanding as reported			28,410		29,484		28,482		29,615
		Net income per diluted share as adjusted, before    the effect of the restructuring charges,    net of taxes	$	0.92	$	1.12	$	0.91	$	1.15

CONSOLIDATED BALANCE SHEET DATA

(Unaudited)

(In thousands)

		December 31, 2006	June 30, 2006			December 31, 2005
Cash	$	43,375	$	28,466	$	20,957
Accounts Receivable, Net		263,373		181,080		221,939
Inventories		308,811		269,270		227,261
Property and Equipment, Net		38,398		34,681		32,625
Exclusive Brand Licenses, Trademarks and Intangibles, Net		218,843		201,534		184,908
Total Assets		913,833		759,903		725,985
Short-Term Debt		114,600		40,000		20,474
Current Portion of Long-Term Debt		1,125		563		8,802
Current Liabilities		366,474		234,978		198,503
Long-Term Liabilities		247,890		247,078		234,351
Total Debt		340,670		265,951		254,276
Shareholders' Equity		299,469		277,847		293,132
Working Capital		282,527		280,942		301,341